Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review

Padmaja Sudhakar1, David M Bachman, Alexander S Mark

  • 1Departments of Neurology (PS), University of Kentucky College of Medicine, Lexington, Kentucky; Departments of Ophthalmology (DMB), and Radiology (ASM), Washington Hospital Center, Washington, District of Columbia; Department of Neurology (JRB), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and Department of Neurological Sciences and Ophthalmology (SK), University of Nebraska Medical Center, Omaha, Nebraska.

Abstract

Insights

Visual complaints are common in progressive multifocal leukoencephalopathy (PML), often presenting the first sign. Early recognition of these neuro-ophthalmic symptoms aids in timely diagnosis and management of PML.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Ophthalmology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a severe, often fatal, opportunistic central nervous system infection.
  • Caused by JC virus reactivation, PML typically presents with white matter lesions but can affect gray matter.
  • Visual complaints are a frequent manifestation of PML.

Observation:

  • Neuro-ophthalmic signs occurred in 20%-50% of PML patients, presenting initially in half of these cases.
  • Cerebral visual pathway damage leads to visual field defects and cortical blindness.
  • Ocular motility disorders are less common due to reduced infratentorial involvement.

Findings:

  • Visual symptoms are a significant and often initial presentation of PML.
  • Damage to visual pathways is the primary cause of visual complaints in PML.
  • The frequency of visual complaints underscores the importance of neuro-ophthalmic evaluation in PML.

Implications:

  • Increased awareness of visual symptoms in PML can expedite diagnosis and treatment.
  • Prompt diagnosis of PML is crucial for managing the underlying condition and improving outcomes.
  • Established diagnostic criteria and risk mitigation strategies are available for high-risk populations.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K